Ownership Summary
The institutional landscape for ENDRA Life Sciences Inc. (NASDAQ:NDRA) includes 5 filers as of the latest reporting cycle ending September 2025.
- The percentage of ENDRA Life Sciences owned by institutions changed from 0.6% in June 2025 to 1.7% in September 2025, marking a slight up trend.
- Quarterly data indicates a 123.08% shift in institutional share volume, and the annual owner count reflects a decrease of 44.44%.
- The latest 13F cycle for ENDRA Life Sciences reveals that of 5 total investors, 1 funds grew their exposure, whereas 2 reduced theirs and 2 made no changes.
- The total number of shares held by institutions in ENDRA Life Sciences increased to 13.09K as of September 2025, a net change of up by 7.22K shares quarter on quarter, and down 141.54K shares year over year.
- DRW Securities, LLC continues to be the largest institutional holder of ENDRA Life Sciences as of September 30, 2025, with a position of 12.71K shares, representing 1.69% of the company's outstanding stock.
- Among the most significant buyers of ENDRA Life Sciences during September 2025 were DRW Securities, LLC (12.71K).
- Leading sellers of ENDRA Life Sciences stock in September 2025 included UBS Group AG (4.59K), Tower Research Capital LLC (TRC) (905).
- The top 5 institutional holders of ENDRA Life Sciences for the quarter ending September 2025 included DRW Securities, LLC (12.71K), Tower Research Capital LLC (TRC) (225), UBS Group AG (106), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (35), BANK OF AMERICA CORP /DE/ (6).